Metropolitan Health Networks (NYSE: MDF) reported earnings on Mar. 6. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Dec. 31 (Q4), Metropolitan Health Networks missed slightly on revenues and whiffed on earnings per share.

Compared to the prior-year quarter, revenue increased significantly and GAAP earnings per share shrank significantly.

Gross margins improved, operating margins increased, net margins shrank.

Revenue details
Metropolitan Health Networks reported revenue of $175.1 million. The two analysts polled by S&P Capital IQ expected to see net sales of $178.1 million on the same basis. GAAP reported sales were 92% higher than the prior-year quarter's $91.4 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
Non-GAAP EPS came in at $0.13. The two earnings estimates compiled by S&P Capital IQ predicted $0.19 per share on the same basis. GAAP EPS of $0.06 for Q4 were 57% lower than the prior-year quarter's $0.14 per share.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 24.2%, 590 basis points better than the prior-year quarter. Operating margin was 14.0%, 310 basis points better than the prior-year quarter. Net margin was 1.6%, 500 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $200.4 million. On the bottom line, the average EPS estimate is $0.25.

Next year's average estimate for revenue is $781.5 million. The average EPS estimate is $0.86.

Investor sentiment
The stock has a four-star rating (out of five) at Motley Fool CAPS, with 220 members out of 232 rating the stock outperform, and 12 members rating it underperform. Among 37 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 33 give Metropolitan Health Networks a green thumbs-up, and four give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Metropolitan Health Networks is buy, with an average price target of $8.71.

Over the decades, small-cap stocks, like Metropolitan Health Networks have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.